Us Bancorp \De\ Apellis Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$78.3 Billion
Q2 2025

A detailed history of Us Bancorp \De\ transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 3,056 shares of APLS stock, worth $58,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,056

Previous 2,345 30.32%

Holding current value

$58,064

Previous $51,000 1.96%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	BUY	$16.36 - $23.0 $11,631 - $16,353	711 Added 30.32%	3,056 $52,000
Q1 2025 May 08, 2025	SELL	$21.87 - $34.63 $19,201 - $30,405	-878 Reduced 27.24%	2,345 $51,000
Q4 2024 Feb 05, 2025	BUY	$26.18 - $35.42 $34,740 - $47,002	1,327 Added 69.99%	3,223 $102,000
Q3 2024 Oct 28, 2024	SELL	$28.84 - $41.15 $28,349 - $40,450	-983 Reduced 34.14%	1,896 $54,000
Q2 2024 Aug 06, 2024	SELL	$38.07 - $59.71 $26,154 - $41,020	-687 Reduced 19.27%	2,879 $110,000
Q1 2024 May 07, 2024	SELL	$55.39 - $72.47 $15,176 - $19,856	-274 Reduced 7.14%	3,566 $209,000
Q4 2023 Feb 09, 2024	SELL	$37.14 - $64.82 $2,154 - $3,759	-58 Reduced 1.49%	3,840 $229,000
Q3 2023 Nov 03, 2023	BUY	$23.65 - $89.22 $60,638 - $228,760	2,564 Added 192.2%	3,898 $148,000
Q2 2023 Aug 09, 2023	BUY	$76.68 - $93.31 $1,763 - $2,146	23 Added 1.75%	1,334 $121,000
Q1 2023 May 09, 2023	BUY	$46.59 - $66.96 $27,814 - $39,975	597 Added 83.61%	1,311 $86,000
Q4 2022 Feb 13, 2023	SELL	$43.24 - $61.04 $153,631 - $216,875	-3,553 Reduced 83.27%	714 $36,000
Q3 2022 Oct 27, 2022	BUY	$44.76 - $69.66 $174,653 - $271,813	3,902 Added 1069.04%	4,267 $291,000
Q2 2022 Aug 01, 2022	SELL	$35.07 - $59.21 $26,127 - $44,111	-745 Reduced 67.12%	365 $17,000
Q1 2022 May 11, 2022	BUY	$35.46 - $54.12 $31,346 - $47,842	884 Added 391.15%	1,110 $56,000
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $3,596 - $5,751	-117 Reduced 34.11%	226 $11,000
Q3 2021 Nov 10, 2021	BUY	$31.4 - $69.84 $6,374 - $14,177	203 Added 145.0%	343 $12,000
Q2 2021 Aug 05, 2021	BUY	$40.9 - $64.9 $1,349 - $2,141	33 Added 30.84%	140 $9,000
Q4 2020 Feb 04, 2021	BUY	$30.79 - $57.2 $2,370 - $4,404	77 Added 256.67%	107 $6,000
Q3 2020 Nov 10, 2020	SELL	$25.89 - $33.65 $1,113 - $1,446	-43 Reduced 58.9%	30 $1,000
Q2 2020 Aug 07, 2020	BUY	$24.8 - $38.49 $1,810 - $2,809	73 New	73 $2,000

Others Institutions Holding APLS

# of Institutions

286

Shares Held

124M

Call Options Held

921K

Put Options Held

761K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.09B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account